Iluvien

Product manufactured by Alimera Sciences, Inc.

Application Nr Approved Date Route Status External Links
NDA201923 None Intravitreal None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage IluvienĀ® (Fluocinolone Acetonide Intravitreal Implant) 0.19 Mg Is Indicated For The Treatment Of Diabetic Macular Edema (Dme) In Patients Who Have Been Previously Treated With A Course Of Corticosteroids And Did Not Have A Clinically Significant Rise In Intraocular Pressure. Iluvien Contains A Corticosteroid And Is Indicated For The Treatment Of Diabetic Macular Edema (Dme) In Patients Who Have Been Previously Treated With A Course Of Corticosteroids And Did Not Have A Clinically Significant Rise In Intraocular Pressure. (1)

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Fluocinolone Acetonide

Comments